眼科

• 论著 • 上一篇    下一篇

5%复方利多卡因乳膏缓解眼睑痉挛患者注射A型肉毒毒素相关疼痛的效果

李越  王文鲜  董桂霞   

  1. 100730首都医科大学附属北京同仁医院护理部(李越);100730首都医科大学附属北京同仁医院 北京同仁眼科中心 眼科学与视觉科学北京市重点实验室(王文鲜、董桂霞)
  • 收稿日期:2019-03-22 出版日期:2019-05-25 发布日期:2019-06-06
  • 通讯作者: 王文鲜,Email:13581586953@163.com E-mail:13581586953@163.com
  • 基金资助:

    首都医科大学附属北京同仁医院院内基金(2017-YJJ-HLL-005)

Efficiency of 5% compand lidocaine cream on alleviating pain from botulinum toxin A injections for blepharospasm

LI Yue1, WANG Wen-xian2, DONG Gui-xia2   

  1. 1. Nursing Department, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China; 2. Beijing Tongren Eye Center, Beijing Key Laboratory of  Ophthalmology and Visual Sciences, Beijing Tongren Hospital,  Capital Medical University,  Beijing 100730, China
  • Received:2019-03-22 Online:2019-05-25 Published:2019-06-06
  • Contact: WANG Wen-xian, Email: 13581586953@163.com E-mail:13581586953@163.com

摘要:

目的 评价5%复方利多卡因乳膏缓解眼睑痉挛患者注射A型肉毒毒素相关疼痛的效果。设计 病例对照研究。研究对象 采取便利抽样法,选取24例2018年8-12月在北京同仁医院因眼睑痉挛接受A型肉毒毒素注射治疗,且在既往未给予疼痛干预情况下,视觉模拟评分法(visual analogue scale,VAS)疼痛评分≥8分的患者。方法 采用数字随机法随机确定观察眼的眼别,观察眼眼睑注射部位在注射前给予5%复方利多卡因乳膏涂抹30分钟,对侧眼眼睑注射部位未予干预作为对照。注射后立即应用VAS对患者进行疼痛评分,2周后随访,记录其他不良反应。主要指标 VAS疼痛评分、不良反应。结果 24例观察眼的VAS疼痛评分为6.73±1.25,对照眼为8.68±0.42(P=0.000),随访期间未观察到明显不良反应。结论 5%利多卡因乳膏可以安全、有效地缓解眼睑痉挛患者接受A型肉毒毒素注射时的相关疼痛,可临床推广应用。

关键词: 眼睑痉挛, 复方利多卡因乳膏, A型肉毒毒素, 疼痛

Abstract:

Objective  To evaluate the efficiency of 5% compand lidocaine cream on alleviating pain from botulinum toxin A (BTX-A) injections for bilateral blepharospasm. Design Case-controlled study. Participants 24 patients who were treated with BTX-A  injections for bilateral blepharospasm in Beijing Tongren Hospital were selected from August 2018 to December 2018 and whose previous VAS pain score was not less than 8 without pain intervention. Methods BTX-A injections were given in both eyes of the patients. 5% compand lidocaine cream was applied for 30 minute prior to BTX-A injections on one side (right-left design by random number table, observed side), whereas the other side received BTX-A injections only (control side). Patients completed VAS pain score immediately after injections and were followed up 2 weeks later to observe the side-effects. Main Outcome Measures VAS pain score, side effects. Results The average pain score of all 24 patients was 6.73±1.25 on the observed side and 8.68±0.42 on the control side (P=0.000). All 24 patients experienced no significant side effects during the follow-up period. Conclusion 5% compand lidocaine cream represents a safe and effective means to alleviate pain from botulinum toxin A injections for bilateral blepharospasm patients.

Key words: blepharospasm, compand lidocaine cream, botulinum toxins A, pain